$VMCA
Valuence Merger Corp I

2022 Q4 Form 10-K Financial Statement

#000149315223010256 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.162M $2.617M
YoY Change 26252.17%
Operating Profit -$2.617M
YoY Change
Interest Expense $1.898M $3.247M
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.247M
YoY Change
Pretax Income $735.7K $630.6K
YoY Change -6450.45%
Income Tax
% Of Pretax Income
Net Earnings $735.7K $630.6K
YoY Change -6450.47%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.03 $0.03
COMMON SHARES
Basic Shares Outstanding 22.01M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $319.2K $319.2K
YoY Change 78.62%
Cash & Equivalents $319.2K
Short-Term Investments
Other Short-Term Assets $522.4K $522.4K
YoY Change 14.38%
Inventory
Prepaid Expenses $522.4K
Receivables
Other Receivables
Total Short-Term Assets $841.6K $841.7K
YoY Change 370.99% 32.45%
LONG-TERM ASSETS
Property, Plant & Equipment $5.000M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $229.9M $229.9M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $229.9M $229.9M
YoY Change 50243.28%
TOTAL ASSETS
Total Short-Term Assets $841.6K $841.7K
Total Long-Term Assets $229.9M $229.9M
Total Assets $230.8M $230.8M
YoY Change 36218.72% 36218.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.989M $1.989M
YoY Change
Accrued Expenses $70.00K $70.00K
YoY Change -78.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.258M $2.258M
YoY Change 263.94% 263.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $8.105M $8.105M
YoY Change
Total Long-Term Liabilities $8.105M $8.105M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.258M $2.258M
Total Long-Term Liabilities $8.105M $8.105M
Total Liabilities $10.36M $10.36M
YoY Change 1570.45% 1570.45%
SHAREHOLDERS EQUITY
Retained Earnings -$9.522M
YoY Change 95793.64%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.522M $220.4M
YoY Change
Total Liabilities & Shareholders Equity $230.8M $230.8M
YoY Change 36218.72% 36218.83%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $735.7K $630.6K
YoY Change -6450.47%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$144.1K -$1.150M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 -$226.7M
YoY Change
Cash From Investing Activities $0.00 -$226.7M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 $228.0M
YoY Change 127484.14%
NET CHANGE
Cash From Operating Activities -144.1K -$1.150M
Cash From Investing Activities 0.000 -$226.7M
Cash From Financing Activities 0.000 $228.0M
Net Change In Cash -144.1K $140.5K
YoY Change -21.37%
FREE CASH FLOW
Cash From Operating Activities -$144.1K -$1.150M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001892747
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2021Q4 VMCAU Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
VMCAU Proceeds From Sale Of Units Net Of Underwriting Discounts Paid
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
VMCAU Proceeds From Advances From Related Party
ProceedsFromAdvancesFromRelatedParty
usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2022 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
VMCAU Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
usd
CY2022 VMCAU Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
usd
CY2022 VMCAU Deferred Offering Costs Paid Through Promissory Note Related Party
DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41304
CY2022 dei Entity Registrant Name
EntityRegistrantName
VALUENCE MERGER CORP. I
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
4 Orinda Way
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100D
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Orinda
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94563
CY2022 dei City Area Code
CityAreaCode
(415)
CY2022 dei Local Phone Number
LocalPhoneNumber
340-0222
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
220319729.60 usd
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York, New York
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
319201 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
178698 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
522444 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
841645 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
178698 usd
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
456764 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
229949989 usd
CY2022Q4 us-gaap Assets
Assets
230791634 usd
CY2021Q4 us-gaap Assets
Assets
635462 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1989469 usd
CY2022Q4 VMCAU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
70000 usd
CY2021Q4 VMCAU Accrued Offering Costs Current
AccruedOfferingCostsCurrent
320015 usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
198384 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
377 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
300000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2257853 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
620392 usd
CY2022Q4 VMCAU Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
8105480 usd
CY2022Q4 us-gaap Liabilities
Liabilities
10363333 usd
CY2021Q4 us-gaap Liabilities
Liabilities
620392 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
229949989 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24425 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9522238 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9930 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9521688 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15070 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
230791634 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
635462 usd
CY2022 VMCAU Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
70000 usd
VMCAU Offering Costs Included In Accrued Offering Costs
OfferingCostsIncludedInAccruedOfferingCosts
320015 usd
CY2022 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
2616768 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9930 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2616768 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-9930 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3247370 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3247370 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
630602 usd
us-gaap Net Income Loss
NetIncomeLoss
-9930 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9930 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15070 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15070 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
10401993 usd
CY2022 VMCAU Adjustments To Additional Paid In Capital Fair Value Of Public Warrants Net Of Transaction Costs
AdjustmentsToAdditionalPaidInCapitalFairValueOfPublicWarrantsNetOfTransactionCosts
5942690 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
325177 usd
CY2022 VMCAU Adjustments To Additional Paid In Capital Accretion Of Common Stock Subject To Redemption
AdjustmentsToAdditionalPaidInCapitalAccretionOfCommonStockSubjectToRedemption
-26186866 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
630602 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
630602 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9521688 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9521688 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
630602 usd
us-gaap Net Income Loss
NetIncomeLoss
-9930 usd
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
3247370 usd
us-gaap Share Based Compensation
ShareBasedCompensation
5000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
4930 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
522444 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1989469 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1149743 usd
CY2022 us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
226702619 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226702619 usd
CY2022 VMCAU Proceeds From Sale Of Units Net Of Underwriting Discounts Paid
ProceedsFromSaleOfUnitsNetOfUnderwritingDiscountsPaid
218300626 usd
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
10401993 usd
CY2022 VMCAU Proceeds From Advances From Related Party
ProceedsFromAdvancesFromRelatedParty
198007 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
300000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
300000 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
10059 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
607761 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
111243 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
227992865 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
178698 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
140503 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
178698 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
178698 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
319201 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
178698 usd
CY2022 VMCAU Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
8105480 usd
VMCAU Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBOrdinaryShares
20000 usd
VMCAU Deferred Offering Costs Paid Through Promissory Note Related Party
DeferredOfferingCostsPaidThroughPromissoryNoteRelatedParty
5506 usd
CY2022Q1 us-gaap Deposits
Deposits
20702619 usd
CY2022Q1 VMCAU Deposits Per Unit
DepositsPerUnit
10.30
CY2022Q1 VMCAU Proceeds Deposit In Trust Account
ProceedsDepositInTrustAccount
226702619 usd
CY2022 VMCAU Transaction Costs
TransactionCosts
10718994 usd
CY2022 us-gaap Other Underwriting Expense
OtherUnderwritingExpense
4000000 usd
CY2022 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
2200996 usd
CY2022 VMCAU Deferred Underwriting Fees
DeferredUnderwritingFees
8105480 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
814510 usd
CY2022 VMCAU Percentage Assets Held In The Trust Account
PercentageAssetsHeldInTheTrustAccount
0.80 pure
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000001 usd
CY2022 VMCAU Payment To Dissolution Expenses
PaymentToDissolutionExpenses
100000 usd
CY2022Q4 us-gaap Share Price
SharePrice
10.00
CY2022Q4 us-gaap Cash
Cash
319201 usd
CY2022Q4 VMCAU Working Capital
WorkingCapital
1416208 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zCoAv74fsmGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash
Cash
319201 usd
CY2021Q4 us-gaap Cash
Cash
178698 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022 us-gaap Proceeds From Other Equity
ProceedsFromOtherEquity
220099630 usd
CY2022 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
5942690 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
-10393817 usd
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
26186866 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
229949989 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zcQOaX2PXZ42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Concentration of Credit Risk</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20221231_z1guABQxqc1h" title="Cash FDIC insured amount">250,000</span>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2021Q4 us-gaap Related Party Costs
RelatedPartyCosts
25000 usd
CY2021Q4 VMCAU Common Stock Shares Subject To Forfeiture
CommonStockSharesSubjectToForfeiture
750000 shares
CY2022 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
(A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
1500000 usd
CY2022Q1 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
198384 usd
CY2022Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
198384 usd
CY2021Q4 us-gaap Due To Other Related Parties Classified Current
DueToOtherRelatedPartiesClassifiedCurrent
377 usd
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 VMCAU Equity Proceeds Percentage
EquityProceedsPercentage
0.60 pure
CY2022 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
vmcau-20221231_cal.xml Edgar Link unprocessable
vmcau-20221231_lab.xml Edgar Link unprocessable
0001493152-23-010256-index-headers.html Edgar Link pending
0001493152-23-010256-index.html Edgar Link pending
0001493152-23-010256.txt Edgar Link pending
0001493152-23-010256-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-5.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vmcau-20221231.xsd Edgar Link pending
vmcau-20221231_def.xml Edgar Link unprocessable
vmcau-20221231_pre.xml Edgar Link unprocessable